PATENT CLAIM ANALYSIS

Application Number: 16122416
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "348000"]

Abstract:
Methods and compositions for use in treating, attenuating, preventing or improving liver fibrosis in a subject are described. The compounds of the present invention are gamma-ketoaldehyde scavengers.

Claim (Index 5):
The method of  claim 1 , wherein the compound is selected from the formula: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12865668', '13523519', '13003514', '13386387', '11025373']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7096199217483619
- 35 USC 102 Novelty (BERT): 0.5052097863240635
- Combined Prediction Score: 0.6891789082059321
- Mean Citation Score: 242.45498000000003
- Max Citation Score: 247.73665
- Similarity Product: 172.6747847335756

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test